E.M. Bypass Medical Centre Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 29-07-2024
- Paid Up Capital ₹ 7.02 M
as on 29-07-2024
- Company Age 25 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 307.37%
(FY 2023)
- Profit 68.77%
(FY 2023)
- Ebitda -254.42%
(FY 2023)
- Net Worth -38.34%
(FY 2023)
- Total Assets -10.49%
(FY 2023)
About E.M. Bypass Medical Centre
The Corporate was formerly known as East India Urology & Nephrology Research Centre Pvt Ltd. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.02 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Bajoria, Latika Bajoria, Akash Bajoria, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110WB1999PTC090043
- Company No.
090043
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at E.M. Bypass Medical Centre?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Latika Bajoria  | Director | 11-Aug-1999 | Current |
| Suresh Bajoria | Director | 11-Aug-1999 | Current |
| Akash Bajoria | Director | 02-Nov-2016 | Current |
| Sarvesh Bajoria | Director | 02-Nov-2016 | Current |
Financial Performance of E.M. Bypass Medical Centre.
E.M. Bypass Medical Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 307.37% increase. The company also saw a substantial improvement in profitability, with a 68.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of E.M. Bypass Medical Centre?
In 2023, E.M. Bypass Medical Centre had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Latika Biotech Private LimitedActive 10 years 7 monthsLatika Bajoria, Akash Bajoria and 1 more are mutual person
Latika Infotech Private LimitedActive 13 years 5 monthsSuresh Bajoria, Latika Bajoria and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at E.M. Bypass Medical Centre?
Unlock and access historical data on people associated with E.M. Bypass Medical Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of E.M. Bypass Medical Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped E.M. Bypass Medical Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
